These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 229859)

  • 1. The effects of incorporation into microsomes of purified NADPH-cytochrome c (P-450) reductase on drug oxidations.
    Kitada M; Kitagawa H; Kamataki T
    Biochem Pharmacol; 1979 Sep; 28(17):2670-3. PubMed ID: 229859
    [No Abstract]   [Full Text] [Related]  

  • 2. Stimulation of microsomal drug oxidation activities by incorporation into microsomes of purified NADPH-cytochrome c (P-450) reductase.
    Kitada M; Kubota K; Kitagawa H; Kamataki T
    Jpn J Pharmacol; 1979 Dec; 29(6):877-87. PubMed ID: 120463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between the reduction of oxygen, artificial acceptors and cytochrome P-450 by NADPH--cytochrome c reductase.
    Lyakhovich V; Mishin V; Pokrovsky A
    Biochem J; 1977 Nov; 168(2):133-9. PubMed ID: 202259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic isotope effects in cytochrome P-450-catalyzed oxidation reactions. II. Interactions of cytochrome P-450 with substrates and NADPH-cytochrome C reductase.
    Lu AY; Miwa GT; West SB; Hodshon BJ; Garland WA
    Adv Exp Med Biol; 1980; 132():95-108. PubMed ID: 6775516
    [No Abstract]   [Full Text] [Related]  

  • 5. Purification and properties of cytochrome P-450 and NADPH-cytochrome c (P-450) reductase from human liver microsomes.
    Kamataki T; Sugiura M; Yamazoe Y; Kato R
    Biochem Pharmacol; 1979 Jul; 28(13):1993-2000. PubMed ID: 113009
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the rate-limiting enzyme component in the microsomal monooxygenase system. Incorporation of purified NADPH-cytochrome c reductase and cytochrome P-450 into rat liver microsomes.
    Miwa GT; West SB; Lu AY
    J Biol Chem; 1978 Mar; 253(6):1921-9. PubMed ID: 416020
    [No Abstract]   [Full Text] [Related]  

  • 7. Dissociation of microsomal ethanol oxidation from cytochrome P-450 catalyzed drug metabolism.
    Vatsis KP; Schulman MP
    Adv Exp Med Biol; 1975; 58(00):369-82. PubMed ID: 239541
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of ketamine induction of hepatic microsomal drug metabolism.
    Marietta MP; Vore ME; Way WL; Trevor AJ
    Biochem Pharmacol; 1977 Dec; 26(24):2451-3. PubMed ID: 413552
    [No Abstract]   [Full Text] [Related]  

  • 9. Hydroxyl radical production in a purified NADPH--cytochrome c (P-450) reductase system.
    Lai CS; Grover TA; Piette LH
    Arch Biochem Biophys; 1979 Apr; 193(2):373-8. PubMed ID: 111620
    [No Abstract]   [Full Text] [Related]  

  • 10. [Interrelationship between the generation of oxygen anion-radicals and the reduction of artificial acceptors and cytochrome P-450 by NADPH-cytochrome c reductase].
    Liakhovich VV; Mishin VM; Pokrovskii AG
    Biokhimiia; 1977 Jul; 42(7):1323-30. PubMed ID: 198028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver microsomal drug-metabolizing enzyme system: functional components and their properties.
    Lu AY
    Fed Proc; 1976 Nov; 35(13):2460-3. PubMed ID: 824157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-electron reduction of mitomycin c by rat liver: role of cytochrome P-450 and NADPH-cytochrome P-450 reductase.
    Vromans RM; van de Straat R; Groeneveld M; Vermeulen NP
    Xenobiotica; 1990 Sep; 20(9):967-78. PubMed ID: 2122607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reconstruction of the liver microsomal monooxygenase system in a solution from NADP-H-cytochrome P-450 reductase and cytochrome P-450 monomers].
    Skotselias ED; Kanaeva IP; Dzhuzenova ChS; Gordeev SA; Kariakin AV
    Dokl Akad Nauk SSSR; 1987; 293(3):748-51. PubMed ID: 3107957
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro metabolism of terfenadine by a purified recombinant fusion protein containing cytochrome P4503A4 and NADPH-P450 reductase. Comparison to human liver microsomes and precision-cut liver tissue slices.
    Rodrigues AD; Mulford DJ; Lee RD; Surber BW; Kukulka MJ; Ferrero JL; Thomas SB; Shet MS; Estabrook RW
    Drug Metab Dispos; 1995 Jul; 23(7):765-75. PubMed ID: 7587966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical characteristics of purified beef liver NADPH-cytochrome P450 reductase.
    Arinç E; Celik H
    J Biochem Mol Toxicol; 2002; 16(6):286-97. PubMed ID: 12481304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-electron reductive bioactivation of 2,3,5,6-tetramethylbenzoquinone by cytochrome P450.
    Goeptar AR; te Koppele JM; van Maanen JM; Zoetemelk CE; Vermeulen NP
    Biochem Pharmacol; 1992 Jan; 43(2):343-52. PubMed ID: 1310854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NADPH cytochrome P-450 reductase and its role in the mixed function oxidase reaction.
    Strobel HW; Dignam JD; Gum JR
    Pharmacol Ther; 1980; 8(3):525-37. PubMed ID: 6770379
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of banol and paraoxon on the NADPH-cytochrome c reductase activity and cytochrome P-450 content in rats.
    Neskovic NK; Vitorovic SL
    Bull Environ Contam Toxicol; 1977 Oct; 18(4):472-7. PubMed ID: 411532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of cytochrome b5 in cytochrome P-450 enzymes.
    Sasame HA; Thorgeirsson SS; Mitchell JR; Gillette JR
    Adv Exp Med Biol; 1975; 58(00):435-45. PubMed ID: 239544
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatic drug metabolism in normal and vitamin E-deficient female Merino sheep.
    Gourlay GK; Savage JK; Stock BH
    Toxicol Appl Pharmacol; 1977 Mar; 39(3):365-75. PubMed ID: 404728
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.